06 mar 2019
Nail psoriasis in adult patients with no or mild skin psoriasis
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus
06 mar 2019
Distinguishing Idiopathic from Drug-Induced Subacute Cutaneous Lupus Erythematosus
Are there distinct clinical and pathological features distinguishing Idiopathic from Drug-Induced Subacute Cutaneous Lupus Erythematosus? A European retrospective multicenter study
27 feb 2019
Campagna promozionale SIDeMaST - Backstage
Spot girato presso gli uffici SIDeMaST
27 feb 2019
I medici insorgono contro lo spot sui risarcimenti
La Rai lo sospende in "via cautelativa". Le scuse della Bonaccorti
27 feb 2019
È tutto italiano il primato europeo per i casi di dermatite
Il recente convegno organizzato dalla Società Italiana di Dermatologia ha messo in luce un dato abbastanza preoccupante: nessun paese in Europa raggiunge i numeri italiani se si parla di diagnosi di dermatite.
27 feb 2019
Da ansia a dolori muscolari, sale il prezzo di 800 farmaci da banco
In media +5,7% a confezione, quasi un euro in più
27 feb 2019
Dermatologic care for lesbian, gay, bisexual, and transgender persons
Epidemiology, screening, and disease prevention
27 feb 2019
Evaluation of antimicrobial textiles for atopic dermatitis.
Functional textiles have been proposed as safe adjunct treatment for atopic dermatitis (AD). Some data have been published regarding their antimicrobial properties and their clinical efficacy.
27 feb 2019
Italian guidelines in patch testing adapted from the European Society of Contact Dermatitis (ESCD).
"Skin Allergy" group of SIDeMaST and "SIDAPA" (Società Italiana di Dermatologia Allergologica, Professionale e Ambientale).
20 feb 2019
Sanità: Grillo, 'Educazione alla salute nelle scuole barriera a fake news'
Il sistema educativo può essere la prima concreta barriera contro la cattiva informazione e la diffusione di fake news
20 feb 2019
La Sanità integrativa diventa sostitutiva del Ssn
Gimbe, deregulation mina sostenibilità Sistema pubblico
20 feb 2019
Brexit, anche la Fda si sposta da Londra ad Amsterdam
Non è escluso che gli uffici di rappresentanza della Food and drug administration nel Regno Unito si spostino in Olanda per mantenere la vicinanza con Ema
20 feb 2019
Isothiazolinone derivatives and allergic contact dermatitis: a review and update
the epidemiology of contact allergy to different isothiazolinones, clinical presentation of isothiazolinone‐induced ACD, most relevant sensitization sources and potential cross‐reactions between isothiazolinone derivatives
20 feb 2019
A systematic review of evidence-based treatments for prurigo nodularis
Prurigo nodularis is a chronic dermatologic condition involving the development of multiple cutaneous nodules in the setting of intractable pruritus
20 feb 2019
Management of congenital ichthyoses: European guidelines of care, part one.
topical therapies, systemic therapies, psychosocial management, communicating the diagnosis and genetic counselling
12 feb 2019
Idroclorotiazide, AIFA: “Rischio di tumori cutanei non melanoma”
I pazienti che assumono idroclorotiazide da sola o in associazione con altri farmaci devono essere informati del rischio di tumore cutaneo non melanoma
12 feb 2019
Ambiente, Ema vuole rivedere le linee guida per l’impatto dei farmaci
L’Agenzia europea dei medicinali vorrebbe rimettere mano all’Era, ‘Environmental Risk Assessment’, sulla produzione dei medicinali.
12 feb 2019
Cutaneous Photoprotective Activity of a Short-term Ingestion of High Flavanol Cocoa: A Nutritional Intervention study.
In vivo and in vitro studies have shown that prolonged oral administration of flavanol rich cocoas extracts have photoprotective effects.
12 feb 2019
Squamous Cell Carcinoma of the Nail Unit: A Clinical Histopathologic Study and a Proposal for Classification.
BACKGROUND: There is no consensus on the classification, grading, and the treatment of nail squamous cell carcinoma (NSCC).
12 feb 2019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses, and fistulas located in apocrine gland-bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported to be greater than other dermatologic conditions as psoriasis and atopic eczema, and its improvement is an important goal in disease management. Nowadays there are no specific validated QoL instruments available for HS and generic dermatologic questionnaires are used.